A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B
Public ClinicalTrials.gov record NCT03319849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2
Study identification
- NCT ID
- NCT03319849
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Neurotech Pharmaceuticals
- Industry
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Interventions
- NT-501 Combination Product
- Sham Procedure
Combination Product · Procedure
Eligibility (public fields only)
- Age range
- 21 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 21, 2018
- Primary completion
- Aug 30, 2022
- Completion
- Sep 22, 2022
- Last update posted
- Sep 23, 2024
2018 – 2022
United States locations
- U.S. sites
- 22
- U.S. states
- 18
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Vitreous Assoc | Beverly Hills | California | 90211 | — |
| Retina Consultants of Southern Colorado, P.C. | Colorado Springs | Colorado | 80909 | — |
| Emory University Eye Center | Atlanta | Georgia | 30322 | — |
| Northwestern Medical Group | Chicago | Illinois | 60611 | — |
| Elman Retina Group, PA | Baltimore | Maryland | 21237 | — |
| Massachusetts Eye and Ear Infirmary Ophthalmology Clinical Research Office | Boston | Massachusetts | 02114 | — |
| New England Retina Consultants | Springfield | Massachusetts | 01107 | — |
| University of Michigan, Kellogg Eye Center | Ann Arbor | Michigan | 48105 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| The Retina Institute | Chesterfield | Missouri | 63017 | — |
| Retina Center of New Jersey - Envision Ocular, LLC | Bloomfield | New Jersey | 07003 | — |
| Flaum Eye - University of Rochester | Rochester | New York | 14642 | — |
| University of Rochester Strong Memorial Hospital | Rochester | New York | 14642 | — |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45242 | — |
| Tulsa Retina Consultants | Tulsa | Oklahoma | 74114 | — |
| Retina Northwest, PC | Portland | Oregon | 97221 | — |
| Scheie Eye Institute - University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Palmetto Retina Center | West Columbia | South Carolina | 29169 | — |
| Southeastern Retina Associates, PC | Knoxville | Tennessee | 37922 | — |
| Austin Clinical Research, LLC | Austin | Texas | 78705 | — |
| Retina Consultants of Texas | Bellaire | Texas | 77401 | — |
| Retina Center of Texas | Southlake | Texas | 76092 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03319849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 23, 2024 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03319849 live on ClinicalTrials.gov.